Cargando…

Comparison of chronic systolic heart failure guideline adherence for two ambulatory clinics

Guidelines have been published for management of chronic systolic heart failure to reduce patient morbidity and mortality. OBJECTIVE: A quality review of the heart failure medical therapy for a community family medicine residency program clinic and a multidisciplinary heart failure specialty clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehoney, Sarah B., Dickerson, Lori M., Nappi, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140578/
https://www.ncbi.nlm.nih.gov/pubmed/25152794
Descripción
Sumario:Guidelines have been published for management of chronic systolic heart failure to reduce patient morbidity and mortality. OBJECTIVE: A quality review of the heart failure medical therapy for a community family medicine residency program clinic and a multidisciplinary heart failure specialty clinic was performed to compare adherence to ACC/AHA heart failure guidelines, with regard to medications and in titrating to recommended target doses. METHODS: The study was a retrospective chart review and data collected included name and dose of any ACEI, beta-blocker, ARB, or other medication addressed in the guidelines. RESULTS: Specialty clinic patients had significantly lower systolic blood pressures and ejection fractions. Significantly more patients were prescribed beta-blockers in the specialty clinic population (98% vs 80%, p<0.05). Both patient populations had very low rates of reaching target beta-blocker doses (15% vs 21%, p=0.27). More patients in the family medicine clinic reached target doses of ACEI (64% vs 49%, p<0.05) and ARBs (67% vs 35%, p<0.05). CONCLUSIONS: This study revealed the vast majority of patients in either a community family medicine residency program or heart failure specialty clinic were prescribed ACEI or ARB, and beta-blockers. However, achieving target doses should continue to be an important goal for practitioners.